Host directed therapies: COVID-19 and beyond

The global spread of SARS-CoV-2 has necessitated the development of novel, safe and effective therapeutic agents against this virus to stop the pandemic, however the development of novel antivirals may take years, hence, the best alternative available, is to repurpose the existing antiviral drugs wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathi, Devavrat, Sodani, Megha, Gupta, Pramod Kumar, Kulkarni, Savita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
COVID-19 therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464038/
https://www.ncbi.nlm.nih.gov/pubmed/34870156
http://dx.doi.org/10.1016/j.crphar.2021.100058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464038/
https://www.ncbi.nlm.nih.gov/pubmed/34870156
http://dx.doi.org/10.1016/j.crphar.2021.100058

Ejemplares similares